[Question] mechanism — what am I missing here
mechanism — what am I missing here. I am not trying to be the "source?" guy. I would just like a source. Glucose-dependent insulin secretion is why hypoglycaemia risk is low as monotherapy: the effect scales with glycaemia rather than acting unconditionally. Tolerance to the gastric effect develops with continued…
Is there any human data on that mechanism yet?
a mechanism you can state is not a mechanism you have demonstrated
the peripheral and central stories are not in competition
Is there any human data on that mechanism yet?
Disagreeing with this specific inference — that is a preclinical result being read as human pharmacology.
Correction: that is glucose-dependent insulin secretion, which is why hypoglycaemia risk is low as monotherapy. Not the same claim as you made.
albumin binding is most of the half-life story